Cargando…

Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation

Hyperinsulinemia is a major risk factor for equine laminitis, a debilitating and painful foot condition. Sweet taste receptor (T1R2/3) inhibitors have been used to reduce the insulin and glucose responses to oral carbohydrates in other species. However, their effect in horses has not been investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: de Laat, Melody Anne, Kheder, Murad Hasan, Pollitt, Christopher Charles, Sillence, Martin Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025858/
https://www.ncbi.nlm.nih.gov/pubmed/29958298
http://dx.doi.org/10.1371/journal.pone.0200070
_version_ 1783336357673828352
author de Laat, Melody Anne
Kheder, Murad Hasan
Pollitt, Christopher Charles
Sillence, Martin Nicholas
author_facet de Laat, Melody Anne
Kheder, Murad Hasan
Pollitt, Christopher Charles
Sillence, Martin Nicholas
author_sort de Laat, Melody Anne
collection PubMed
description Hyperinsulinemia is a major risk factor for equine laminitis, a debilitating and painful foot condition. Sweet taste receptor (T1R2/3) inhibitors have been used to reduce the insulin and glucose responses to oral carbohydrates in other species. However, their effect in horses has not been investigated. It would be useful to be able to attenuate the large post-prandial insulin response that typically occurs when a carbohydrate-rich meal is fed to insulin-dysregulated horses. Here we have determined the efficacy of two T1R2/3 inhibitors, lactisole and Gymnema sylvestre, for reducing glucose uptake by the equine small intestine in vitro; and post-prandial insulin secretion in ponies in vivo, following a carbohydrate-based meal. We used gas chromatography-mass spectrometry to measure 2-deoxyglucose uptake by explants of small intestine, in the presence and absence of the T1R2/3 inhibitors. Lactisole and G sylvestre reduced 2-deoxyglucose uptake by the intestinal explants by 63% (P = 0.032) and 73% (P = 0.047), respectively, compared to control samples. The study in vivo investigated the effect of the inhibitors on the blood glucose and serum insulin responses to a meal containing D-glucose. Three doses of each inhibitor were tested using a Latin square design, and each dose was compared to a meal with no inhibitor added. Lactisole had no effect on glucose and insulin concentrations, whereas G sylvestre was partially effective at reducing post-prandial blood glucose (by ~10%) and serum insulin concentrations (~25%) in seven ponies, with a most effective dose of 10 mg/kg bodyweight. These data provide preliminary support that T1R2/3 inhibitors may be a useful therapeutic strategy for the management of equine insulin dysregulation and the prevention of laminitis. However, further optimisation of the dose and delivery method for these compounds is required, as well as a direct investigation of their activity on the equine sweet taste receptor.
format Online
Article
Text
id pubmed-6025858
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-60258582018-07-07 Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation de Laat, Melody Anne Kheder, Murad Hasan Pollitt, Christopher Charles Sillence, Martin Nicholas PLoS One Research Article Hyperinsulinemia is a major risk factor for equine laminitis, a debilitating and painful foot condition. Sweet taste receptor (T1R2/3) inhibitors have been used to reduce the insulin and glucose responses to oral carbohydrates in other species. However, their effect in horses has not been investigated. It would be useful to be able to attenuate the large post-prandial insulin response that typically occurs when a carbohydrate-rich meal is fed to insulin-dysregulated horses. Here we have determined the efficacy of two T1R2/3 inhibitors, lactisole and Gymnema sylvestre, for reducing glucose uptake by the equine small intestine in vitro; and post-prandial insulin secretion in ponies in vivo, following a carbohydrate-based meal. We used gas chromatography-mass spectrometry to measure 2-deoxyglucose uptake by explants of small intestine, in the presence and absence of the T1R2/3 inhibitors. Lactisole and G sylvestre reduced 2-deoxyglucose uptake by the intestinal explants by 63% (P = 0.032) and 73% (P = 0.047), respectively, compared to control samples. The study in vivo investigated the effect of the inhibitors on the blood glucose and serum insulin responses to a meal containing D-glucose. Three doses of each inhibitor were tested using a Latin square design, and each dose was compared to a meal with no inhibitor added. Lactisole had no effect on glucose and insulin concentrations, whereas G sylvestre was partially effective at reducing post-prandial blood glucose (by ~10%) and serum insulin concentrations (~25%) in seven ponies, with a most effective dose of 10 mg/kg bodyweight. These data provide preliminary support that T1R2/3 inhibitors may be a useful therapeutic strategy for the management of equine insulin dysregulation and the prevention of laminitis. However, further optimisation of the dose and delivery method for these compounds is required, as well as a direct investigation of their activity on the equine sweet taste receptor. Public Library of Science 2018-06-29 /pmc/articles/PMC6025858/ /pubmed/29958298 http://dx.doi.org/10.1371/journal.pone.0200070 Text en © 2018 de Laat et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
de Laat, Melody Anne
Kheder, Murad Hasan
Pollitt, Christopher Charles
Sillence, Martin Nicholas
Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation
title Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation
title_full Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation
title_fullStr Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation
title_full_unstemmed Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation
title_short Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation
title_sort sweet taste receptor inhibitors: potential treatment for equine insulin dysregulation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025858/
https://www.ncbi.nlm.nih.gov/pubmed/29958298
http://dx.doi.org/10.1371/journal.pone.0200070
work_keys_str_mv AT delaatmelodyanne sweettastereceptorinhibitorspotentialtreatmentforequineinsulindysregulation
AT khedermuradhasan sweettastereceptorinhibitorspotentialtreatmentforequineinsulindysregulation
AT pollittchristophercharles sweettastereceptorinhibitorspotentialtreatmentforequineinsulindysregulation
AT sillencemartinnicholas sweettastereceptorinhibitorspotentialtreatmentforequineinsulindysregulation